Resmed Inc (RMD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 5,146,327 | 4,685,297 | 4,222,993 | 3,578,127 | 3,196,825 |
| Cost of Goods | 2,091,357 | 2,029,994 | 1,867,331 | 1,553,816 | 1,357,725 |
| Gross Profit | 3,054,970 | 2,655,303 | 2,355,662 | 2,024,311 | 1,839,100 |
| Operating Expenses | 1,367,576 | 1,271,182 | 1,203,665 | 1,024,025 | 926,749 |
| Operating Income | 1,687,394 | 1,384,121 | 1,151,997 | 1,000,286 | 912,351 |
| Interest Expense | N/A | 45,708 | N/A | N/A | 23,989 |
| Other Income | -9,828 | -73,615 | -50,333 | -39,803 | -4,700 |
| Pre-tax Income | 1,677,566 | 1,264,798 | 1,101,664 | 960,483 | 883,662 |
| Income Tax | 276,843 | 243,847 | 204,108 | 181,046 | 409,157 |
| Net Income Continuous | 1,400,723 | 1,020,951 | 897,556 | 779,437 | 474,505 |
| Net Income | $1,400,723 | $1,020,951 | $897,556 | $779,437 | $474,505 |
| EPS Basic Total Ops | 0.96 | 0.69 | 0.61 | 0.53 | 0.33 |
| EPS Basic Continuous Ops | 0.96 | 0.69 | 0.61 | 0.53 | 0.33 |
| EPS Diluted Total Ops | 0.95 | 0.69 | 0.61 | 0.53 | 0.32 |
| EPS Diluted Continuous Ops | 0.95 | 0.69 | 0.61 | 0.53 | 0.32 |
| EBITDA(a) | $1,923,205 | $1,526,715 | $1,349,559 | $1,194,127 | $1,099,169 |